DNA甲基化组分析识别与绝经后乳腺癌易感性相关的表观遗传加速衰老
该研究嵌套于欧洲癌症与营养前瞻性调查(EPIC)队列的病例对照研究(n=960),用Illumina 450K芯片和Horvath方法计算表观遗传年龄。内在表观遗传年龄加速(IEAA)与乳腺癌风险相关(OR 1.04,95%CI 1.007-1.076,P=0.016),绝经后乳腺癌风险关联更强(OR 1.07,95%CI 1.020-1.11,P=0.003)。CpG岛平均甲基化升高与乳腺癌风险增加相关(每1 SD OR 1.20,95%CI 1.03-1.40,P=0.02)。
要点
- IEAA每增加1单位,乳腺癌发生比值增加4%(OR 1.04,95%CI 1.007-1.076,P=0.016)。
- 绝经后乳腺癌中IEAA关联更强(OR 1.07,95%CI 1.020-1.11,P=0.003)。
- CpG岛平均甲基化每升高1 SD,乳腺癌风险OR 1.20(95%CI 1.03-1.40,P=0.02)。
核心结论
- 表观遗传年龄加速和CpG岛甲基化与乳腺癌易感性呈弱但统计学显著的关联。
研究设计与样本
- 嵌套于欧洲癌症与营养前瞻性调查(EPIC)队列的病例对照研究,样本量n=960。
- 使用Illumina HumanMethylation 450K BeadChip芯片检测DNA甲基化,采用Horvath年龄估计方法计算表观遗传年龄。
- 内在表观遗传年龄加速(IEAA)通过将表观遗传年龄对实际年龄回归所得的残差来估计。
主要发现
- IEAA与乳腺癌风险相关(OR 1.04,95%CI 1.007-1.076,P=0.016)。
- IEAA每增加1单位,乳腺癌发生比值增加4%(OR 1.04,95%CI 1.007-1.076)。
- 按绝经状态分层分析,IEAA与绝经后乳腺癌发生相关(OR 1.07,95%CI 1.020-1.11,P=0.003)。
- 全甲基化组分析显示,CpG岛平均DNA甲基化较高与乳腺癌风险增加相关(每1 SD OR 1.20,95%CI 1.03-1.40,P=0.02)。
- 非岛CpG的平均甲基化水平在癌症病例与对照之间无差别。
关键数值与推荐
- IEAA与乳腺癌风险:OR 1.04(95%CI 1.007-1.076,P=0.016)。
- 绝经后乳腺癌:IEAA OR 1.07(95%CI 1.020-1.11,P=0.003)。
- CpG岛平均甲基化每1 SD:OR 1.20(95%CI 1.03-1.40,P=0.02)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM OF THE STUDY: A vast majority of human malignancies are associated with ageing, and age is a strong predictor of cancer risk. Recently, DNA methylation-based marker of ageing, known as 'epigenetic clock', has been linked with cancer risk factors. This study aimed to evaluate whether the epigenetic clock is associated with breast cancer risk susceptibility and to identify potential epigenetics-based biomarkers for risk stratification. METHODS: Here, we profiled DNA methylation changes in a nested case-control study embedded in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (n = 960) using the Illumina HumanMethylation 450K BeadChip arrays and used the Horvath age estimation method to calculate epigenetic age for these samples. Intrinsic epigenetic age acceleration (IEAA) was estimated as the residuals by regressing epigenetic age on chronological age. RESULTS: We observed an association between IEAA and breast cancer risk (OR, 1.04; 95% CI, 1.007-1.076, P = 0.016). One unit increase in IEAA was associated with a 4% increased odds of developing breast cancer (OR, 1.04; 95% CI, 1.007-1.076). Stratified analysis based on menopausal status revealed that IEAA was associated with development of postmenopausal breast cancers (OR, 1.07; 95% CI, 1.020-1.11, P = 0.003). In addition, methylome-wide analyses revealed that a higher mean DNA methylation at cytosine-phosphate-guanine (CpG) islands was associated with increased risk of breast cancer development (OR per 1 SD = 1.20; 95 %CI: 1.03-1.40, P = 0.02) whereas mean methylation levels at non-island CpGs were indistinguishable between cancer cases and controls. CONCLUSION: Epigenetic age acceleration and CpG island methylation have a weak, but statistically significant, association with breast cancer susceptibility.
引用
- Ambatipudi S, Horvath S, Perrier F, et al. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility. Eur J Cancer. 2017. PMID: 28259012. doi:10.1016/j.ejca.2017.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。